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Abstract
Background: Manual removal of the placenta is an invasive obstetric procedure commonly used for the management
of retained placenta. However, it is unclear whether antibiotic prophylaxis is beneficial in preventing infectious morbidity.
We conducted a systematic review to determine the efficacy and safety of routine use of antibiotics for preventing
adverse maternal outcomes related to manual placenta removal following vaginal birth.
Methods: A detailed search of MEDLINE, EMBASE, Cochrane library and the CINAHL databases was conducted for
non-randomized studies involving women undergoing manual placenta delivery after vaginal births and where
antibiotic prophylaxis use was compared with no treatment or placebo to prevent maternal infection. Search terms
including ‘delivery, obstetric’, ‘placenta, retained’, ‘anti-infective agents’, and ‘chemoprevention’ were used.
Results: Of the 407 citations that resulted after elimination of duplicates, 81 full texts were potentially eligible
after independent assessment of the title and abstracts. Independent review of the full texts identified three
eligible cohort studies which were retrospective in design. These studies contained data on two of the pre-
specified outcomes, endometritis and puerperal fever. Other secondary outcomes such as perineal infection
and/or any infection, hospital stay duration, sepsis, hemorrhage >1000 ml or hospital readmissions were not
reported on excluding puerperal fever.
A meta-analysis showed no significant reduction in the incidence of endometritis (odds ratio [OR] 0.84, 95 %
confidence interval [CI] 0.38 to 1.85, three studies, 567 women) and puerperal fever (OR 0.99, 95 % CI 0.38 to
2.27, one study, 302 women).
Conclusions: There is currently no evidence to suggest beneficial effects for routine antibiotic use in women
undergoing manual placental removal following vaginal birth. In appropriate settings, further research is required to
determine whether a policy of routine antibiotic prophylaxis for the procedure should be maintained or discouraged.
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Background
In the third stage of labor, after delivery of the infant,
the placenta spontaneously detaches from the myome-
trium [1, 2]. When this does not occur, the placenta is
said to be ‘retained’. Studies have shown underlying pla-
cental and/or uterine abnormalities to be risk factors for
a retained placenta [3]. The time frame for diagnosis
post-delivery is still ambiguous, however, a 30–60 min
time lapse is widely accepted [4, 5]. Existing reviews re-
ported a varying incidence of 1.5–2.7 % in low-resource
to high-resource settings respectively, using a 30-min
mark-off point [5, 6].
Manual removal of the placenta is indicated if controlled
cord traction and the use of uterotonics fails [6–8]. This
procedure involves insertion of the hand into the uterus
with the aim of separating the placenta from the implant-
ation site, and therefore carries a possible risk of contam-
ination in the uterine cavity. Antibiotic prophylaxis,
usually broad spectrum, is routinely administered to re-
duce infectious morbidities and/or mortalities [9–12]. No
evidence exists from randomized control studies or sys-
tematic reviews supporting or refuting the practice.
A Cochrane review on the subject initially conducted
in 2006 and updated in 2014 did not identify any eligible
randomized controlled study [13]. Synthesizing evidence
from non-randomized studies is justified in the absence
of randomized studies and has been shown to corrobor-
ate results from randomized studies regardless of the
subject [14]. Hence, we conducted a systematic review
on available data from relevant non-randomized studies
to determine the efficacy of routine prophylactic antibi-
otics and if efficacious, the optimal antibiotic regimen
for the procedure. This study was conceived as part of
the preparation of the evidence base for the World
Health Organization (WHO) recommendations for pre-
vention and treatment of maternal peripartum infections.
Methods
Search strategy
Based on a pre-specified protocol prepared in line with
guidelines in the Cochrane Handbook for Systematic Re-
views [14], we conducted a detailed search on January
28, 2015 for eligible studies on MEDLINE, EMBASE, the
Cochrane Library and CINAHL databases using specific
search terms that included ‘delivery’, ‘obstetric’, ‘placenta’,
‘retained’, ‘anti-infective agents’ and ‘chemoprevention’
(see Appendix S1).
Initially, studies were selected if they were conducted
to answer either of these two questions: (1) What are
the effects of routine antibiotic prophylaxis on maternal
infectious morbidities and mortality, when used for
manual removal of the placenta in vaginal deliveries?;
and, (2) What is the comparative effectiveness and safety
of different antibiotic regimens used for preventing in-
fectious maternal morbidities during manual removal of
the placenta? This systematic review was conducted in
accordance with the principles of Declaration of
Helsinki. Due to the study design, there was no need for
ethics approval as the studies were freely available in the
public domain.
Eligibility criteria
All non-randomized studies involving women undergo-
ing manual placental removal after vaginal birth, where
the use of antibiotics was compared with no treatment
or placebo for prophylaxis against maternal infection.
Cluster, quasi-randomized control studies, controlled-
before-after studies, cohort and case-control studies
were all eligible for inclusion. Comparative studies that
reported on comparative use of antibiotic prophylaxis
for vaginal births were included while similar studies ad-
dressing same comparison but in operative deliveries or
a mixed population of operative and vaginal deliveries
were excluded, as were studies that contained no data
on individual delivery methods.
Data collection and assessment
For this systematic review, the Preferred Reporting Items
for Systematic Reviews and Meta-Analyses [15] (PRISMA)
method of reporting was used.
The titles and abstracts of all resulting citations from
search strategy were examined independently for eligibil-
ity by two review authors (CEC and AJQP) irrespective
of the publication status (published and unpublished) or
language of publication.
Table 1 Characteristics of included studies
Author, year Study design Total
study
population











et al. 1988 [22]
Retrospective
cohort study
302 65/237 An undefined
period of 6 years
Germany Women undergoing manual
placental removal
Endometritis, fever







61/104 1990–1994 Norway Women who underwent a
manual placenta removal
Endometritis
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After the removal of duplicates, selected studies were
then retrieved and further evaluated for inclusion on the
basis of full-text appraisal. Disagreements were resolved
by discussions with the third review author (EO). Data
extraction using a standardized form was performed in-
dependently by two review authors (CEC and AJQP),
which included information on the study design, facil-
ities, participants, settings and outcomes.
Pre-specified outcomes included infectious morbidities
common to obstetric procedures. [5, 16]. Primary out-
come was postpartum endometritis as defined by the au-
thors and secondary outcomes included puerperal fever
defined as temperature of 38.0 °C or higher, perineal in-
fections, hospital stay duration, sepsis, postpartum
hemorrhage, hospital readmission, drug side effects, and
neonatal-related outcomes (jaundice, sepsis, intensive
care unit admission).
Rating the methodological quality of eligible studies
was performed independently by two review authors
(CEC and AJQP) using the Newcastle Ottawa scale [17],
which involved assessing the methods of participant
selection, comparability and outcomes among eligible
studies. The quality of the evidence obtained from in-
cluded studies were further assessed using the Grading
of Recommendations Assessment, Development and
Evaluation (GRADE) approach [18–20].
Data analysis/synthesis
Data from included studies (Table 1) was pooled and
meta-analysis conducted using a random effects model.
Meta-analysis was performed using Revman 5.3 accord-
ing to the meta-analysis of observational studies in epi-
demiology (MOOSE) guidelines.
A Mantel Haenszel model for sparse dichotomous data
was applied, and adjusted using the random-effects
model and presented as odds ratios with a 95 % confi-
dence interval (CI), a p-value of 0.05 and heterogeneity
estimates of Tau2 and I2.
Results
The titles and abstracts of 407 studies that were identi-
fied from the keyword search of relevant databases after
Fig. 1 Flow diagram of search results and study selection
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elimination of duplicates were independently assessed by
two review authors (CEC and AJQP). After initial
screening, the full texts of 81 potentially eligible studies
were retrieved for further appraisal (Fig. 1). A sizeable
number of studies on the subject were published in English
and other foreign languages, however, these studies merged
data for both vaginal and operative deliveries and were
therefore ineligible for inclusion. Only three studies met
the inclusion criteria.
Effects of antibiotic prophylaxis on infectious maternal
morbidities in vaginal deliveries involving manual placenta
removal
All three eligible studies were retrospective in design
and conducted in hospitals in Norway (1999),
Bulgaria (1983) and Germany (1988) [21–23]. The
study population and intervention were consistent
across studies. Antibiotics for prophylaxis were intro-
duced for manual placenta removal after placenta re-
tention was diagnosed and women with a prior
history of fever were ineligible for inclusion in the
study population. All three studies reported on the
pre-specified primary outcome, postpartum endomet-
ritis. All secondary outcomes (perineal infection and/
or any infection, hospital stay duration, sepsis,
hemorrhage >1000 ml, hospital readmissions) were
not reported on excluding puerperal fever. Only one
of the eligible studies reported on this.
Two studies reported on the antibiotic agent used.
Von Rechlin et al. [22] used Mebacid/Sulfamerazine
(at least over 10 days, 1 g per 1 day and then 0.5 g
daily), while Katsulov [21] used 2 g cefamandole
(cephalosporin family) for an unstated short duration.
In the third study [23], the antibiotic prophylaxis
agent was unnamed and the dosage was not given.
The authors reported routine use of antibiotics in the
center, with the practice maintained throughout the
study period.
Both studies loosely defined endometritis as fever
greater than 37.5 °C in addition to clinical evidence (not
clearly stated in either paper, though probably based on
clinician’s judgment) and puerperal fever was defined as a
persistent or uninterrupted temperature record of 37.5 °C.
The third study was published in English and better
defined endometritis as a temperature of 38.0 °C, exces-
sive uterine tenderness or elevated C-reactive protein
(±50 mg/l).
Von Rechlin et al. [22] reported a comparable incidence
of fever in both the prophylaxis group (89.2 %) and the
control group (89.9 %). The other two studies [21, 22]
reported only on endometritis as an outcome. Both studies
showed no difference between the intervention and control
group. Katsulov [21] showed no incidence of endometritis
in the prophylaxis group (0 %) compared to control
(10.1 %), although this difference was not significant.
Tandberg et al. [23] detected a similar incidence of
Fig. 2 Maternal outcomes: a Puerperal fever, b Endometritis. Adjusted odds ratio for antibiotic prophylaxis versus no prophylaxis in manual placenta
removal procedures during vaginal delivery
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endometritis in both the prophylaxis (1.6 %) and control
(1.9 %) groups.
Follow-up periods ranged from the period of adminis-
tration of antibiotics (6 days) to the 1st month postpar-
tum, although the period was unstated in Von Rechlin
et al. [22].
A meta-analysis similarly showed no difference be-
tween prophylaxis and non-prophylaxis groups. For
puerperal fever, no difference was observed between
groups (odds ratio (OR) 0.93, 95 % confidence inter-
val (CI) 0.38 to 2.27, one study, 302 women).
Similarly, incidence of endometritis was similar in both
groups (OR 0.84, 95 % CI 0.38 to 1.85, three studies, 567
women) (Fig. 2). No adverse effects or other secondary
outcomes were reported, and no heterogeneity was ob-
served across studies.
Assessment of eligible studies using the Newcastle
Ottawa Scale generally showed a low quality of evi-
dence (Table 2), and both outcomes (endometritis
and fever) were judged very low in overall quality
using the GRADE tool (Table 3).
Prophylactic antibiotic regimen for reduction of maternal
infectious morbidities during manual placenta removal in
vaginal birth
No eligible studies were found comparing antibiotic clas-
ses or regimens for prophylaxis in vaginal deliveries in-
volving manual placenta removal.
Discussion
Main findings
No significant benefit was observed for the routine use
of prophylactic antibiotics on the reduction of maternal
febrile morbidities or postpartum endometritis for man-
ual placenta removal. However, the low quality of evi-
dence limits definite conclusions.
Included studies were comparable in terms of study
population, intervention and outcome. All three studies
individually showed no difference between the control
and experimental groups for both fever and endometritis
outcomes.
Meta-analysis further showed a similar incidence of re-
ported maternal morbidities (fever and endometritis)
Table 2 Newcastle-Ottawa Scale (NOS) risk of bias assessment for included studies
NOS (Newcastle-Ottawa Scale) risk of bias assessment for included studies






Representativeness of exposed cohort
- Truly representative of the average woman (*)
- Somewhat representative of the average woman (*)
- Selected group of users-No description of the derivation of the cohort
Selection of non-exposed cohort
- Drawn from the same community as the exposed cohort (*)
- Drawn from a different source
- No description of the derivation of the non-exposed cohort
Ascertainment of exposure
- Secure records (e.g., surgical records) (*)
- Structured interview (*)
- Written self-report
- No description




Comparability of cohorts on the basis of the design or analysis
- Study controls for gestational age and/or birth weight (*)
- Study controls for any additional factor (*)
*
Assessment of outcome-Independent blind assessment (*)
- Record linkage (*)-Self-report-No description
* *




Adequacy of follow-up of cohorts
- Complete follow-up – all subjects accounted for (*)
- Subjects lost to follow-up unlikely to introduce bias, or description provided of those lost (*)
- No statement
* * *
Total number of stars 2 5 3
Chibueze et al. BMC Pregnancy and Childbirth  (2015) 15:313 Page 5 of 8
Table 3 GRADE tables (Non-randomized studies)
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7.1 % 11 fewer per 1000 (from 43
fewer to 53 more)
Question: Antibiotic prophylaxis versus none for manual placental delivery during vaginal birth
Settings: Hospitals in Germany, Norway and Bulgaria
aStudy contributing data had design limitations based on Newcastle Ottawa Scale rating, non-randomized data collection














between groups. In the random effects analysis, the Von
Rechlin study weighted 81 % of the pooled weight and
appears to favor the use of antibiotic prophylaxis com-
pared to no prophylaxis, though this should be inter-
preted with caution due to the study’s small sample size
and low quality of evidence.
Strengths and limitations
No evidence exists to date that assesses routine anti-
biotic prophylaxis for manual placental removal in vagi-
nal birth. This systematic review provides comparable
alternative evidence to currently lacking randomized
controlled studies and may represent the only systematic
evidence available on the subject.
The detailed search strategy, methodology, statistical
analyses, absence of statistical heterogeneity and language
restrictions, however, lends credence to this review.
Inclusion of studies published in languages other than
English ensured the inclusion of important studies on
the subject.
This review was limited to evidence from a small number
of low quality non-randomized studies and few outcomes
due to a clear absence of randomized studies on the sub-
ject. Three studies met the inclusion criteria and reported
on only two outcomes. Collated data was from observa-
tional studies conducted in two developed countries
(Germany and Norway) and one developing country
(Bulgaria) and may not be globally representative or applic-
able as policies on antibiotic administration may vary across
income settings. The lack of heterogeneity across studies
further adds to the validity of the study.
Routine antibiotic prophylaxis is increasingly associ-
ated with, antibiotic resistance [24]. Its administration
needs to be assessed in the light of emerging resistance
and inherent benefits to justify and balance recommen-
dations for routine use; however, eligible studies in-
cluded in this review failed to report on these points.
In addition, no reports were found on other outcomes
in any of the eligible studies or any data comparing the
use of different types of prophylactic antibiotics for man-
ual placenta removal in vaginal deliveries. This restricted
our evaluation of the effectiveness of routine antibiotic
prophylaxis or the definition of an optimal regimen.
Studies aiming to determine optimal doses may prove
helpful in the future.
Conclusion
Available evidence is insufficient to support routine anti-
biotic prophylaxis for manual placental removal follow-
ing vaginal birth. This study highlights the need for
robust randomized control studies in both low- and
high-income settings that will incorporate relevant out-
comes such as adverse effects of prophylaxis. Knowledge
of this may help inform better assessment of the efficacy
of routine antibiotic prophylaxis in obstetric vaginal
procedures. The decision to administer antibiotics for
manual placenta removal should be selective and based
on a balance between the inherent value to the patient
and the clinician experience in the light of increasing
antibiotic resistance.
Increase in antibiotic resistance in recent years high-
lights the need for selective prophylaxis to be integrated
into best practice and policy against a background of
existing area-specific norms and policies.
Successful prevention of maternal infectious morbid-
ities and mortalities resulting from manual removal of
the placenta in vaginal births may prove invaluable to-
wards maternal health improvement.
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